BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/28/2014 9:54:00 AM | Browse: 945 | Download: 1229
 |
Received |
|
2013-09-29 18:02 |
|
Peer-Review Started |
|
2013-09-30 14:38 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2013-10-28 12:08 |
|
Revised |
|
2013-11-15 03:38 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2014-01-06 18:19 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2014-01-06 19:00 |
|
Articles in Press |
|
|
|
Edit the Manuscript by Language Editor |
|
2014-03-12 13:37 |
|
Typeset the Manuscript |
|
2014-04-17 09:19 |
|
Publish the Manuscript Online |
|
2014-05-14 10:58 |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Topic Highlights |
| Article Title |
Helicobacter pylori: Management in 2013
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Yesim Ozen Alahdab and Cem Kalayci |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Yesim Ozen Alahdab, MD, Department of Gastroenterology and Hepatology, Fatih Sultan Mehmet Education and Research Hospital, E5 Karayolu Uzeri Icerenkoy-Atasehir, 34752 Istanbul, Turkey. yesimalahdab@yahoo.com |
| Key Words |
Helicobacter pylori; First-line therapy; Second-line therapy; Rescue therapy |
| Core Tip |
Helicobacter pylori (H. pylori) is a prevalent, worldwide, chronic infection. The ideal therapy regimen for H. pylori infection should achieve an eradication rate ≥ 80%. Triple therapy remains an appropriate first-line therapy in areas of low clarithromycin resistance, and quadruple therapy should be the first-line therapy in areas of high clarithromycin resistance. Sequential therapy can be an alternative. Levofloxacin-containing regimens or concomitant therapies can be good choices for second-line therapy. Choice of treatment regimen for H. pylori infection should be done cautiously and antibiotic-resistance rates should be taken into consideration. |
| Publish Date |
2014-05-14 10:58 |
| Citation |
Alahdab YO, Kalayci C. Helicobacter pylori: Management in 2013. World J Gastroenterol 2014; 20(18): 5302-5307 |
| URL |
http://www.wjgnet.com/1007-9327/full/v20/i18/5302.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v20.i18.5302 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
